The influence of the pharmaceutical industry on the off-label use of its medicines

Journal of Medical Ethics 28 (4):277-277 (2002)
  Copy   BIBTEX

Abstract

Last year I described in this journal1 an unacceptable influence of a pharmaceutical company on the off-label use of one of its products. Now I would like to report on an acceptable and even praiseworthy initiative of a pharmaceutical manufacturer in monitoring the use of its drug. The devastating action of thalidomide on the human embryo caused its withdrawal from the market in …

Other Versions

No versions found

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 101,139

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

Similar books and articles

Analytics

Added to PP
2010-08-24

Downloads
60 (#356,604)

6 months
20 (#147,431)

Historical graph of downloads
How can I increase my downloads?

Citations of this work

No citations found.

Add more citations

References found in this work

Misoprostol in a topsyturvy world.D. O. E. Gebhardt - 2001 - Journal of Medical Ethics 27 (3):205-205.

Add more references